The leading biologics, ADCs, & bioconjugates CDMO + CRO.

Abzena Cambridge - Hero

Abzena is a biopharmaceutical CDMO & CRO that provides fully integrated, tailored drug design, development and manufacturing services spanning from early discovery through commercial.

Let's work together to move medicine forward.

We enable you to bring life-changing medicines to patients in need. Let’s work together to de-risk & streamline the development and manufacture of your biologic or antibody-drug conjugate (ADC).

Let’s move you from promise to product.

Let’s work together to move medicine forward

The asset you are developing right now can make a real difference for patients in need. We offer best-in-class CDMO + CRO services along with a highly detailed and personalized experience deploying the best technologies, shortening lead times, and implementing effective risk mitigation strategies. That means our customer’s bioconjugate, ADC or biologic programs can go from promise to product, faster.

What you can come to expect when you partner with Abzena:

Access to Genuine Scientific & Technical Experts
Proactive Solutions for Streamlining Development
Diverse and Interconnected Teams
End-to-End Support Under One Organization

Abzena are advocates and partners for our customers’ success.

We are bioconjugate and biologics-focused CDMO + CRO partner with:

Fully integrated early R&D through commercial capabilities
High-quality & trusted data that drives development
Streamlined regulatory support tailored to your program

At Abzena we aim to start smart, and finish fast, ‘Developability’ balances the scales of an ideal drug candidate vs the challenges faced.

Abzena San Diego, CA

Abzena Announces Major Expansion in Microbiology Laboratory Space in Support of Biologic Manufacturing

Increased Capacity, Efficiency, and Tools Help Abzena Ensure Higher Standards of Quality for Customers San Diego, CA – October 30, 2024 – Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant expansion in their quality control (QC) testing capabilities ...
Gary Watts - Abzena

Pharmaceutical Technology: Navigating the Complexities of Drug Formulation

Abzena’s Senior Manager in Analytics, Gary Watts shares his formulation development views in the latest edition of Pharmaceutical Technology. Gary’s article entitled ‘Navigating the Complexities of Drug Formulation’ covers the complexities of formulation development, which is the cornerstone ...
Darren Bird - Abzena

A Look into Project Management: Colleague Spotlight on Darren Bird

In the CDMO & CRO industry, Project Coordinators play a pivotal part in ensuring that customer’s biopharmaceutical projects run smoothly across various departments and sites. At Abzena’s Cambridge, UK facility, Darren Bird, fills this essential position with a unique ...
Biologic Discovery, Development & Manufacturing - Abzena

Webinar: Always Look on the Bright Side of (Cell) Death: Cytotoxicity Assays for Antibody Drug Conjugate Development

In partnership with Promega, Abzena’s experts Grant Harradence and Robert Francis PhD FRMS will be taking part in a webinar hosted by them entitled ‘Always Look on the Bright Side of (Cell) Death: Cytotoxicity Assays for Antibody Drug Conjugate ...

Drug Discovery 2024

Connect with Abzena’s Robert Francis PhD at Drug Discovery 2024 and learn more about our latest developments in cell imaging at poster number 177 at the ELRIG conference https://elrig.org/portfolio/drug-discovery-2024/, 2nd – 3rd October. ‘Application of Real-Time Live Cell ...

Basel Lunch Seminar: Mastering the Art of Developing a Successful Bispecific Antibody

One design doesn’t fit all: The short journey to a successful bispecific therapeutic antibody Transitioning from single-functional antibodies to sophisticated bispecific designs not only introduces unique challenges for drug developers but also demands innovative approaches. Unlike traditional antibodies, bispecifics ...
EpiScreen® 2.0 Time Course Assay: A Sensitive & Data-Rich Tool for Pre-Clinical Immunogenicity Testing of Biologic - Abzena Poster

EpiScreen® 2.0 Time Course Assay: A Sensitive & Data-Rich Tool for Pre-Clinical Immunogenicity Testing of Biologic

Complex Chemistry for Antibody-Drug Conjugates and Beyond - Abzena Info Sheet

Complex Chemistry for Antibody-Drug Conjugates and Beyond

Streamlining Bioconjugation for Antibody-Drug Conjugate Development - Abzena Info Sheet

Streamlining Bioconjugation for Antibody-Drug Conjugate Development

"Abzena has been crucial in advancing and validating our technology and programs. The team is very thoughtful, has strong troubleshooting skills and maintains a high standard in generating quality data with integrity. We highly recommend working with Abzena."

Shiva Bhowmik, PhD

Shiva Bhowmik, PhD | COO
TRIO Pharmaceuticals, Inc.

Explore customer testimonials
"I’ve never had a CRO project go this smoothly and the ADCs delivered were very high quality. I’m confident that my client will put Abzena at the top of their list for future ADC projects."



David Jackson

David Jackson | Pharmaceutical Consultant & ADC Expert
DYJ Pharma Consulting

Explore customer testimonials
“Throughout the development of AGX101, Abzena has worked closely with us to achieve successful GMP manufacturing and quality control. We could not have reached this milestone without Abzena’s expertise, cooperation, and support.”


Paul Jaminet

Paul Jaminet | Co-founder & CEO
Angiex

Explore customer testimonials
"We worked with the Abzena team for the design and the initial production of both the mAb and the antibody-chelator conjugate to support our R&D programs. We had a productive and valuable interaction with a highly skilled scientific team and we benefited from the flexibility of the services at this early stage of development."
Tina Bjørnlund Bønsdorff

Tina Bjørnlund Bønsdorff | CSO
Oncoinvent AS

Explore customer testimonials

5 Discovery & Manufacturing Facilities Across 3 Cities

Cambridge, UK

Development, Discovery

Abzena Cambridge specializes in the early discovery, design, and development of complex biologics and bioconjugates.

Bristol, PA, USA

Discovery, Manufacturing

At Abzena Bristol, we specialize in bioconjugation, quality linker payloads, highly potent materials and complex chemistry.

San Diego, CA, USA

Development, Manufacturing

Abzena San Diego boasts a trio of cutting-edge facilities designed to accelerate the development, production, and testing of biologics. 

Ambr® 15 Cell Culture Bioreactor System - Abzena

Let's move medicine forward.

The leading biologics CDMO + CRO that de-risks and accelerates drug development. Let’s move medicine forward for patients in need.